EBITDA: Income before interest, taxes, depreciation and amortization.
Alamar Biosciences, Inc. (ALMR) had EBITDA of $-27.40M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$74.21M |
|
$-29.82M |
|
$32.51M |
|
$41.70M |
|
$105.55M |
|
$-31.33M |
|
$2.18M |
|
$-29.15M |
|
$-29.15M |
|
$-29.82M |
|
$-29.82M |
|
$-29.82M |
|
$-29.82M |
|
$-31.33M |
|
|
EBITDA |
$-27.40M |
11.55M |
|
11.55M |
|
$-2.58 |
|
$-2.58 |
|
| Balance Sheet Financials | |
$94.70M |
|
$10.50M |
|
$45.29M |
|
$139.99M |
|
$23.73M |
|
$9.81M |
|
$40.22M |
|
$63.95M |
|
$-158.95M |
|
$74.05M |
|
$76.04M |
|
12.05M |
|
| Cash Flow Statement Financials | |
$-53.61M |
|
$46.18M |
|
$10.84M |
|
$31.68M |
|
$34.91M |
|
$3.23M |
|
$2.87M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.99 |
|
-- |
|
-- |
|
0.11 |
|
0.13 |
|
56.20% |
|
-42.22% |
|
-42.22% |
|
-36.92% |
|
-39.29% |
|
-40.18% |
|
$-58.98M |
|
-- |
|
-- |
|
-- |
|
0.53 |
|
0.84 |
|
5.82 |
|
62.72 |
|
18.76% |
|
-40.27% |
|
-21.30% |
|
-34.73% |
|
$6.31 |
|
$-5.11 |
|
$-4.64 |
|